Stay updated on Selinexor Combinations in Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Combinations in Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Selinexor Combinations in Refractory Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check41 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check48 days agoChange DetectedNew studies on Selinexor combined with Low-dose Dexamethasone in refractory Multiple Myeloma have been added, while previous studies including combinations with Pomalidomide have been removed.SummaryDifference3%
- Check55 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check63 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.SummaryDifference1.0%
Stay in the know with updates to Selinexor Combinations in Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Combinations in Refractory Multiple Myeloma Clinical Trial page.